๐Ÿ‡บ๐Ÿ‡ธ FDA

Intelligence ยท Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors โ€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ€” searchable for business development and competitive intelligence.

114 results for โ€œGTโ€ Clear

  1. Motion analysis of patients

    Hospital Authority, Hong Kong

    Leg Length Discrepancy

    phase 1 other completed

    1 trial

  2. NGGT002 Injection

    The First People's Hospital of Lianyungang

    Phenylketonurias

    phase 1 gene therapy active

    1 trial

  3. Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulation at 4 different strengths versus the marketed pitolisant (Wakixยฎ) tablet formulation after single oral administrations in healthy subjects

    Bioprojet Pharma

    Narcolepsy, Narcolepsy with cataplexy

    phase 1 other active

    1 trial

  4. SGT-212

    Solid Biosciences

    Friedreich's Ataxia (FA)

    phase 1 small molecule active

    1 trial

  5. SGT-501

    Solid Biosciences

    Catecholaminergic Polymorphic Ventricular Tachycardia

    phase 1 small molecule active

    1 trial

  6. SRP-1005

    Sarepta Therapeutics

    Huntington's Disease

    phase 1 small molecule active

    1 trial

  7. To assess the relative BA of a low-strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents after single dose administration and to assess BE of a regular strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents at steady state in men with prostate cancer

    Janssen-Cilag International N.V.

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 1 other active

    1 trial

  8. sD-NP-GT8 DNA

    INOVIO PHARMACEUTICALS, INC.

    HIV Infections

    phase 1 mab completed

    1 trial

  9. AO-128

    Takeda

    Impaired Glucose Tolerance (IGT)

    approved small molecule completed

    1 trial

  10. Deutetrabenazine

    Teva Pharma GmbH

    Huntington's Disease

    approved small molecule completed

    1 trial

  11. Pantoprazole Teva 40 mg maagsapresistente tabletten, Mycophenolate mofetil Sandoz 500 mg Film-coated Tablets, Mycophenolate Mofetil Accord 500 mg plฤ—vele dengtos tabletฤ—s, CellCept 500 mg film-coated tablets

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial

  12. Stereotactic Radiation Therapy

    GT Biopharma

    Glioblastoma

    approved other terminated

    1 trial

  13. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

  14. Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc

    The First People's Hospital of Lianyungang

    Diabetes

    small molecule active

    1 trial

  15. Low strength nicotine e-liquid

    BRIGHT MINDS BIOSCIENCES INC.

    Electronic Cigarette Use

    small molecule terminated

    1 trial

  16. PIMS screening

    The First People's Hospital of Lianyungang

    PGT-A

    gene therapy active

    1 trial

  17. Semaglutide

    GT Biopharma

    Obesity (Disorder)

    small molecule active

    1 trial

  18. Standard OGTT

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ€“3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources